Mounjaro on NHS UK: Eligibility & Private Options 2025

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro NHS Eligibility UK Price £124.99

Check Mounjaro NHS eligibility and access the cheapest UK price from £124.99 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Your Complete Guide to Getting Mounjaro On NHS

Published on: June 03, 2026

Understanding mounjaro on nhs uk eligibility can be complex, with strict criteria and lengthy waiting lists affecting access. While NHS provision remains limited to specialist weight management services, UK patients can access Mounjaro through private prescription with transparent pricing and clinical oversight from registered pharmacies like Cured Pharmacy.

Current NHS Mounjaro Eligibility Criteria

Mounjaro (tirzepatide) received MHRA licensing for weight management in the UK in 2023, but NHS availability remains severely restricted [1]. NICE guidance currently limits NHS-funded tirzepatide to specialist Tier 3 and Tier 4 weight management services, not standard GP prescribing.

To qualify for Mounjaro on NHS, patients typically must have a BMI of 35 kg/m² or above (or 32.5 kg/m² for those of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [2]. Additionally, you must have completed a structured weight management programme within specialist services.

Most NHS clinical commissioning groups require documented evidence of unsuccessful weight loss attempts through lifestyle interventions, and many operate waiting lists exceeding 12-18 months for initial specialist assessments. Your GP cannot prescribe Mounjaro directly on NHS prescription — referral to a specialist weight management service is mandatory.

NHS Mounjaro Waiting Times and Availability

Current NHS waiting times for specialist weight management services vary dramatically by region, with some areas reporting waits of over two years from GP referral to first appointment. Even after assessment, patients face additional delays for medication initiation due to budget constraints and supply prioritisation.

The NHS tier system creates further barriers. Tier 3 services require completion of behavioural programmes lasting 6-12 months before medication consideration, whilst Tier 4 bariatric services typically reserve Mounjaro for pre-surgical optimisation rather than standalone treatment. Many NHS trusts have suspended new referrals entirely due to capacity limitations.

Supply allocation prioritises NHS patients with type 2 diabetes over those seeking weight management alone, creating additional uncertainty for obesity treatment pathways. These restrictions have led increasing numbers of UK patients to explore private prescription routes for timely access.

Regional Variations in NHS Access

NHS England, Scotland, Wales and Northern Ireland each operate different commissioning frameworks for weight management medications. Some regions maintain closed formularies excluding Mounjaro entirely, whilst others permit use only within research trials or exceptional funding applications. Your local integrated care board determines actual availability regardless of clinical need.

How Mounjaro Works: The Clinical Evidence

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed for weight management in the UK [1]. Unlike single-pathway treatments, tirzepatide activates both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, producing superior metabolic effects through complementary mechanisms.

The SURMOUNT-1 trial demonstrated that patients taking the 15mg maintenance dose achieved an average 22.5% body weight reduction over 72 weeks, significantly exceeding results from semaglutide-based alternatives [3]. Participants also showed meaningful improvements in cardiovascular risk markers including blood pressure, lipid profiles, and inflammatory markers.

Tirzepatide works by slowing gastric emptying, reducing appetite through central nervous system pathways, and improving insulin sensitivity. Clinical trials showed 89% of participants achieved at least 5% weight loss, with 57% reaching 20% or greater reduction — outcomes previously only associated with bariatric surgery [3]. All prescription weight management medications require ongoing lifestyle modifications including dietary changes and increased physical activity for optimal results.

Access Route Eligibility Waiting Time Cost
NHS Specialist Services BMI ≥35 + comorbidity, Tier 3/4 referral required 12-24+ months from GP referral Free at point of care
Private Prescription (Cured Pharmacy) BMI ≥27, clinical assessment required 24-48 hours from consultation From £124.99 per month
Wegovy Private BMI ≥27, clinical assessment required 24-48 hours from consultation From £69.00 per month
Saxenda Private BMI ≥27, clinical assessment required 24-48 hours from consultation From £68.00 per month

Private Prescription Options for Mounjaro

Private prescription through UK-registered pharmacies offers an alternative pathway for patients unable to access NHS provision or facing prohibitive waiting times. At Cured Pharmacy, Mounjaro is available from £124.99 following a free clinical assessment by UK-registered prescribers, with transparent pricing shown upfront before consultation.

The private prescription process begins with a comprehensive online medical questionnaire reviewed by a UK prescriber (typically completed in under 3 minutes). Your clinician assesses eligibility based on BMI, medical history, contraindications, and previous weight management attempts. Approval is subject to the same clinical safety criteria applied in NHS settings, ensuring appropriate patient selection.

Private prescriptions are dispensed with genuine UK-licensed Mounjaro KwikPens, identical to NHS stock, shipped in discreet packaging with next-day delivery options. Ongoing clinical monitoring through follow-up consultations ensures treatment safety and effectiveness, with dose adjustments made according to individual response and tolerability. All prescription medications require clinical assessment — Mounjaro cannot be purchased without prescriber approval.

Private vs NHS: Key Differences

Private prescription eliminates waiting lists and provides direct access to UK prescribers without GP referral requirements. Patients pay for medication costs directly but gain treatment flexibility, faster initiation, and continuity of supply without formulary restrictions. Many find private routes more cost-effective than extended NHS waiting periods when considering lost productivity and delayed health improvements.

Mounjaro Dosing and Treatment Journey

Mounjaro treatment follows a structured dose escalation schedule designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. All patients begin with 2.5mg weekly injections for four weeks, regardless of starting weight or previous medication experience [4].

The dose increases every four weeks in a stepwise progression: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, with a maximum maintenance dose of 15mg weekly. Your prescriber determines progression based on individual tolerance, weight loss response, and side effect profile. Some patients achieve target outcomes at lower maintenance doses and do not require escalation to maximum strength.

Each KwikPen contains four single-dose injections administered subcutaneously into the abdomen, thigh, or upper arm. Injections should occur on the same day each week, with or without food. Clinical trials demonstrated that consistent weekly dosing produced superior outcomes compared to irregular administration patterns [3]. Treatment duration varies by individual goals, but most patients require 12-18 months of therapy combined with lifestyle modifications for sustained weight management.

Alternative Weight Loss Treatments Available

When Mounjaro is unsuitable or unavailable, several alternative prescription weight loss medications are licensed in the UK. Wegovy (semaglutide) is a once-weekly injectable GLP-1 receptor agonist demonstrating average weight loss of 15% over 68 weeks in the STEP trials [5]. Saxenda (liraglutide) requires daily injections but offers a lower entry price point for patients preferring gradual treatment initiation.

Oral medications including Orlistat work through a different mechanism by blocking dietary fat absorption in the intestines, producing more modest weight loss of 5-10% when combined with reduced-calorie diets [6]. Orlistat is available in prescription strength (120mg) as Xenical or lower-dose formulations like Alli and Orlos for over-the-counter purchase.

Your UK prescriber will recommend the most appropriate treatment based on your BMI, medical history, previous medication responses, and personal preferences regarding injection frequency versus oral tablets. Combination approaches incorporating behavioural support, dietary counselling, and physical activity programmes enhance outcomes across all pharmacological interventions. No weight loss medication should be considered a standalone solution — sustainable results require comprehensive lifestyle modifications.

Injectable vs Oral Treatments

Injectable GLP-1 medications like Mounjaro, Wegovy and Saxenda typically produce greater weight loss than oral alternatives but require patient comfort with self-injection techniques. Oral options suit those with needle phobia or preference for tablet-based therapy, though efficacy differences should inform treatment selection. Clinical assessment determines the most suitable option for individual circumstances.

Scientific References

  1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. https://products.mhra.gov.uk/ [accessed 13 August 2026]
  2. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
  3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  4. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
  5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary by individual and depend on adherence to prescribed treatment and lifestyle modifications.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I get Mounjaro on NHS from my GP?
No, GPs cannot prescribe Mounjaro on NHS prescription. Access requires referral to specialist Tier 3 or Tier 4 weight management services, subject to strict eligibility criteria and regional availability.
What BMI do I need for Mounjaro on NHS?
NHS eligibility typically requires BMI ≥35 kg/m² (or ≥32.5 kg/m² for certain ethnic backgrounds) plus at least one weight-related comorbidity. Private prescription criteria are more flexible, generally requiring BMI ≥27 kg/m².
How long is the NHS waiting list for Mounjaro?
NHS waiting times vary by region but commonly exceed 12-18 months from GP referral to specialist assessment, with additional delays before medication initiation. Many areas have suspended new referrals due to capacity constraints.
Is private Mounjaro the same as NHS Mounjaro?
Yes, private pharmacies dispense identical UK-licensed Mounjaro manufactured by Eli Lilly. The medication, dosing schedule, and clinical monitoring requirements are the same regardless of NHS or private prescription route.
How much does Mounjaro cost privately in the UK?
Mounjaro is available from £124.99 at Cured Pharmacy, with pricing varying by prescribed dose. This includes UK prescriber consultation, genuine medication, and discreet delivery — significantly lower than typical market rates.
Do I need to see a doctor for private Mounjaro prescription?
Yes, all Mounjaro prescriptions require clinical assessment by a UK-registered prescriber. Cured Pharmacy provides free online consultations reviewed by qualified prescribers, typically completed in under 3 minutes.
Can I switch from NHS to private Mounjaro prescription?
Yes, patients can transfer to private prescription if NHS supply becomes unavailable or waiting times are prohibitive. Your treatment history and current dose will be reviewed during the private consultation to ensure continuity of care.
What happens if I don't meet NHS criteria for Mounjaro?
Patients who don't meet NHS eligibility thresholds can pursue private prescription, which applies broader clinical criteria. Alternative treatments like Wegovy, Saxenda, or Orlistat may also be appropriate depending on individual circumstances and prescriber assessment.
What is the Mounjaro NHS eligibility criteria in the UK?
Mounjaro NHS eligibility requires a BMI of 35+ with at least one weight-related condition, or BMI 30+ with specific comorbidities, and prior weight management attempts. However, NHS availability is extremely limited with long waiting lists, which is why many choose Cured Pharmacy for immediate private access with full prescriber support.
Can I buy Mounjaro privately if I don't meet NHS eligibility requirements?
Yes, you can access Mounjaro privately through Cured Pharmacy even if you don't meet strict NHS eligibility criteria. Our UK-registered prescribers assess your individual suitability for treatment, often with more flexible clinical guidelines than NHS pathways, ensuring safe and appropriate care.
Is Mounjaro cheaper privately than waiting for NHS eligibility approval?
While NHS prescriptions have standard prescription charges, Mounjaro is rarely available due to NICE restrictions and years-long waiting lists. Cured Pharmacy offers Mounjaro from £124.99 with immediate access, avoiding delays and allowing you to start treatment now rather than waiting indefinitely for NHS eligibility processing.
How long does NHS Mounjaro eligibility assessment take compared to private?
NHS Mounjaro eligibility assessments can take months to over a year due to waiting lists and limited availability, with many patients never gaining access. At Cured Pharmacy, your online consultation is reviewed within 24 hours by UK-registered prescribers, with next-day delivery available once approved.
Does Mounjaro on NHS UK eligibility include all doses or just starting doses?
NHS eligibility for Mounjaro, where available, typically covers dose escalation under specialist supervision, but access remains severely restricted. Cured Pharmacy provides all Mounjaro doses from 2.5mg to 15mg with ongoing prescriber support, allowing proper titration without NHS eligibility barriers or supply interruptions.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.